Log In
Print this Print this

alpha-1 antitrypsin

  Manage Alerts
Collapse Summary General Information
Company Halozyme Therapeutics Inc.
DescriptionSubcutaneous injectable formulation of recombinant human alpha-1 antitrypsin with rHuPH20
Molecular Target Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationEmphysema
Indication DetailsTreat hereditary emphysema
Regulatory Designation
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today